STOCK TITAN

Millennium entities hold 6.51M SKIN shares (5.1%) — The Beauty Health (SKIN)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Millennium Management and affiliated entities reported beneficial ownership of 6,509,750 shares of The Beauty Health Company Class A common stock, representing 5.1% of the class. The filing is a joint Schedule 13G dated 04/17/2026 and states these shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers.

Positive

  • None.

Negative

  • None.

Insights

Large institutional stake reported: 6,509,750 shares (5.1%).

The schedule lists shared voting and dispositive power of 6,509,750 shares held through entities tied to Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. The filing is a joint submission under Schedule 13G with an attached Joint Filing Agreement dated 04/17/2026.

Ownership is disclosed as shared (not sole) control; cash‑flow treatment and specific holding entities are not itemized in the excerpt. Subsequent disclosures or exhibits may list the underlying entities and exact holding vehicles.

Shared voting/dispositive power 6,509,750 shares Shared voting and shared dispositive power reported on Schedule 13G
Percent of class 5.1% Percent of Class A common stock as stated on cover pages
Filing type and date Schedule 13G, 04/17/2026 Joint filing agreement dated April 17, 2026 accompanies the Schedule 13G
CUSIP 88331L108 Class A Common Stock CUSIP as disclosed on the form
Schedule 13G regulatory
"Joint <b>Schedule 13G</b> filing and Joint Filing Agreement dated April 17, 2026"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
shared dispositive power financial
"Shared Dispositive Power 6,509,750.00 shown on cover pages"
Joint Filing Agreement regulatory
"Exhibit I: Joint Filing Agreement, dated as of April 17, 2026"
beneficial ownership financial
"Amount beneficially owned: See response to Item 9 on each cover page"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake did Millennium report in SKIN?

They reported beneficial ownership of 6,509,750 shares, equal to 5.1% of The Beauty Health Company's Class A common stock, as disclosed in the joint Schedule 13G filing dated April 17, 2026.

Who filed the Schedule 13G for SKIN?

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander jointly filed the Schedule 13G and signed a Joint Filing Agreement dated April 17, 2026.

Does the filing show sole voting control over SKIN shares?

No. The filing shows 0 shares of sole voting power and reports 6,509,750 shared voting power, indicating voting and dispositive powers are held jointly through affiliated entities.

When was the joint filing agreement executed for the SKIN disclosure?

The Exhibit I Joint Filing Agreement among the reporting parties is dated April 17, 2026, which accompanies the Schedule 13G submitted for The Beauty Health Company.





88331L108

(CUSIP Number)
04/14/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:04/17/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:04/17/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:04/17/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:04/17/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of April 17, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.